Drug shortages homepage
Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.
Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.
The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.
Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.
If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.
Below are the newest shortage and discontinuation reports and updates to existing ones.
LEGEND
!!T3 denotes an actual Tier 3 shortage/discontinuation
!T3 denotes an anticipated Tier 3 shortage/discontinuation
Shortage Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
SURVANTA | ABBVIE CORPORATION | Resolved | 25MG | Updated Report | 2024-05-11 | 226027 |
VISIPAQUE 270 | GE HEALTHCARE CANADA INC | Actual shortage | 550MG | Updated Report | 2024-05-11 | 227151 |
MIDAZOLAM INJECTION | SANDOZ CANADA INCORPORATED | Resolved | 5MG | Updated Report | 2024-05-11 | 192022 |
AVENTYL | AA PHARMA INC | Resolved | 10MG | Updated Report | 2024-05-11 | 224511 |
BREVICON 0.5/35 TABLETS (28-DAY PACK) | PFIZER CANADA ULC | Actual shortage | .5MG .035MG | Updated Report | 2024-05-11 | 226997 |
ARTHROTEC 75 | PFIZER CANADA ULC | Actual shortage | 200MCG 75MG | Updated Report | 2024-05-11 | 227000 |
ACH-OLMESARTAN HCTZ | ACCORD HEALTHCARE INC | Actual shortage | 40MG 25MG | Updated Report | 2024-05-11 | 227794 |
APO-FINGOLIMOD | APOTEX INC | Actual shortage | 0.5MG | Updated Report | 2024-05-10 | 216744 |
APO-TICAGRELOR | APOTEX INC | Actual shortage | 90MG | Updated Report | 2024-05-10 | 225026 |
APO-WARFARIN | APOTEX INC | Actual shortage | 1MG | Updated Report | 2024-05-10 | 225782 |
APO-WARFARIN | APOTEX INC | Actual shortage | 1MG | Updated Report | 2024-05-10 | 224589 |
APO-ATORVASTATIN | APOTEX INC | Actual shortage | 80MG | Updated Report | 2024-05-10 | 227088 |
METHOTREXATE SUBCUTANEOUS | ACCORD HEALTHCARE INC | Resolved | 20MG | Updated Report | 2024-05-10 | 225687 |
ACH-SOLIFENACIN SUCCINATE | ACCORD HEALTHCARE INC | Actual shortage | 5MG | New Report | 2024-05-10 | 227797 |
COTAZYM | ORGANON CANADA INC. | Anticipated shortage | 35000UNIT 40000UNIT 10000UNIT | Updated Report | 2024-05-10 | 225096 |
PMS-TENOFOVIR | PHARMASCIENCE INC | Actual shortage | 300MG | New Report | 2024-05-10 | 227785 |
APO-TRIMEBUTINE | APOTEX INC | Resolved | 100MG | Updated Report | 2024-05-10 | 225767 |
APO-OXCARBAZEPINE | APOTEX INC | Resolved | 300MG | Updated Report | 2024-05-10 | 224598 |
APO-OXCARBAZEPINE | APOTEX INC | Resolved | 150MG | Updated Report | 2024-05-10 | 219159 |
PMS-METRONIDAZOLE | PHARMASCIENCE INC | Actual shortage | 500MG | New Report | 2024-05-10 | 227776 |
PMS-GABAPENTIN | PHARMASCIENCE INC | Actual shortage | 400MG | Updated Report | 2024-05-10 | 227771 |
PMS-SUMATRIPTAN | PHARMASCIENCE INC | Actual shortage | 50MG | Updated Report | 2024-05-10 | 222384 |
PMS-VALPROIC ACID E.C. | PHARMASCIENCE INC | Actual shortage | 500MG | Updated Report | 2024-05-10 | 153637 |
PMS-VALACYCLOVIR | PHARMASCIENCE INC | Actual shortage | 500MG | Updated Report | 2024-05-10 | 222390 |
PMS-SALBUTAMOL | PHARMASCIENCE INC | Resolved | 2MG | Updated Report | 2024-05-10 | 224605 |
!!T3 OLESTYR | PHARMASCIENCE INC | Actual shortage | 4G | Updated Report | 2024-05-10 | 196455 |
PMS-MEMANTINE | PHARMASCIENCE INC | Resolved | 5.0MG | Updated Report | 2024-05-10 | 214343 |
PMS-LOSARTAN | PHARMASCIENCE INC | Actual shortage | 25MG | Updated Report | 2024-05-10 | 214340 |
PMS-IPRATROPIUM | PHARMASCIENCE INC | Actual shortage | 21MCG | Updated Report | 2024-05-10 | 214337 |
PMS-ESCITALOPRAM | PHARMASCIENCE INC | Actual shortage | 20MG | Updated Report | 2024-05-10 | 204508 |
PMS-ESCITALOPRAM | PHARMASCIENCE INC | Actual shortage | 20MG | Updated Report | 2024-05-10 | 204505 |
PMS-DICLOFENAC-MISOPROSTOL | PHARMASCIENCE INC | Actual shortage | 200MCG 75MG | Updated Report | 2024-05-10 | 222378 |
PMS-DICLOFENAC-MISOPROSTOL | PHARMASCIENCE INC | Actual shortage | 200MCG 50MG | Updated Report | 2024-05-10 | 210336 |
PMS-DICLOFENAC | PHARMASCIENCE INC | Actual shortage | 50MG | Updated Report | 2024-05-10 | 222372 |
PMS-CIPROFLOXACIN XL | PHARMASCIENCE INC | Actual shortage | 500MG | Updated Report | 2024-05-10 | 194525 |
PMS-AMIODARONE | PHARMASCIENCE INC | Resolved | 200MG | Updated Report | 2024-05-10 | 222366 |
!!T3 APO-COLESEVELAM | APOTEX INC | Actual shortage | 625MG | Updated Report | 2024-05-10 | 216646 |
NAT-ESCITALOPRAM | NATCO PHARMA (CANADA) INC | Resolved | 20MG | Updated Report | 2024-05-10 | 218258 |
APO-DOXY CAP 100MG | APOTEX INC | Actual shortage | 100MG | New Report | 2024-05-10 | 227728 |
APO-ATORVASTATIN | APOTEX INC | Actual shortage | 80MG | Updated Report | 2024-05-10 | 227725 |
APO-ACETAMINOPHEN EXTRA STRENGTH | APOTEX INC | Actual shortage | 500MG | New Report | 2024-05-10 | 227722 |
APO-OLMESARTAN | APOTEX INC | Actual shortage | 20MG | Updated Report | 2024-05-10 | 216711 |
APO-SITAGLIPTIN MALATE | APOTEX INC | Actual shortage | 25MG | New Report | 2024-05-10 | 227717 |
APO-VALACYCLOVIR | APOTEX INC | Actual shortage | 1000MG | New Report | 2024-05-10 | 227714 |
APO-VALACYCLOVIR | APOTEX INC | Actual shortage | 500MG | Updated Report | 2024-05-10 | 227031 |
APO-LEFLUNOMIDE | APOTEX INC | Actual shortage | 20MG | Updated Report | 2024-05-10 | 226315 |
APO-ALFUZOSIN | APOTEX INC | Actual shortage | 10MG | Updated Report | 2024-05-10 | 225779 |
APO-DASATINIB | APOTEX INC | Actual shortage | 70MG | Updated Report | 2024-05-10 | 225776 |
APO-TERBINAFINE | APOTEX INC | Actual shortage | 250MG | Updated Report | 2024-05-10 | 225005 |
APO-AMLODIPINE-ATORVASTATIN | APOTEX INC | Actual shortage | 80MG 10MG | Updated Report | 2024-05-10 | 219843 |
Discontinuation Reports
Brand name | Company Name | Status | Strength | Update | Date Updated | View Report |
---|---|---|---|---|---|---|
MYLAN-NITRO SUBLINGUAL SPRAY | MYLAN PHARMACEUTICALS ULC | Discontinued | 0.4MG | New Report | 2024-05-08 | 227338 |
CHAMPIX | PFIZER CANADA ULC | Discontinued | 1MG 0.5MG | New Report | 2024-05-03 | 227052 |
CHAMPIX | PFIZER CANADA ULC | Discontinued | 1MG | New Report | 2024-05-03 | 227049 |
CHAMPIX | PFIZER CANADA ULC | Discontinued | 0.5MG | New Report | 2024-05-03 | 227046 |
AUBAGIO | SANOFI-AVENTIS CANADA INC | To be discontinued | 14MG | New Report | 2024-05-02 | 226847 |
SANDOZ OXYCODONE/ACETAMINOPHEN | SANDOZ CANADA INCORPORATED | Discontinued | 325MG 5MG | Updated Report | 2024-05-02 | 226748 |
SANDOZ OXYCODONE/ACETAMINOPHEN | SANDOZ CANADA INCORPORATED | Discontinued | 325MG 5MG | Updated Report | 2024-05-02 | 226753 |
HUMULIN R | ELI LILLY CANADA INC | To be discontinued | 100UNIT | New Report | 2024-05-02 | 224344 |
SANDOZ D 10 000 | SANDOZ CANADA INCORPORATED | Discontinued | 10000UNIT | Updated Report | 2024-05-02 | 226738 |
SANDOZ DOCUSATE SODIUM | SANDOZ CANADA INCORPORATED | Discontinued | 100MG | Updated Report | 2024-05-02 | 226758 |
PANECTYL | SEARCHLIGHT PHARMA INC | To be discontinued | 2.5MG | New Report | 2024-04-30 | 226633 |
ISENTRESS | MERCK CANADA INC | To be discontinued | 25MG | Updated Report | 2024-04-29 | 204164 |
ISENTRESS | MERCK CANADA INC | To be discontinued | 100MG | Updated Report | 2024-04-29 | 204160 |
PANECTYL | SEARCHLIGHT PHARMA INC | To be discontinued | 5MG | New Report | 2024-04-26 | 226355 |
DELATESTRYL | BAUSCH HEALTH, CANADA INC. | Discontinued | 200MG | Updated Report | 2024-04-26 | 221772 |
STRATTERA | ELI LILLY CANADA INC | Discontinued | 18MG | Updated Report | 2024-04-24 | 171480 |
DULOXETINE | SANIS HEALTH INC | Reversed | 30MG | Updated Report | 2024-04-23 | 219618 |
LIDOCAINE HYDROCHLORIDE INJECTION USP | HIKMA CANADA LIMITED | Discontinued | 10MG | Updated Report | 2024-04-22 | 225805 |
MYLAN-VERAPAMIL | MYLAN PHARMACEUTICALS ULC | Discontinued | 80MG | Updated Report | 2024-04-12 | 224846 |
TD ADSORBED | SANOFI PASTEUR LIMITED | To be discontinued | 5LF 2LF | Updated Report | 2024-04-10 | 206909 |